A comparison of the effectiveness of treatment with Symbicort Turbuhaler (budesonide/formoterol; 160/4.5 mcg) Single Inhaler Therapy and Seretide Diskus (salmeterol/fluticasone; 50/100, 50/250 or 50/500 mcg) plus Ventoline (salbutamole) as needed in steroid-treated adult and adolescent asthmatic subjects. A randomised, open, parallel-group, phase IIIB, multicentre, 12-month study.

Study identifier:SD-039-0691

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A comparison of the effectiveness of treatment with Symbicort Turbuhaler (budesonide/formoterol; 160/4.5 mcg) Single Inhaler Therapy and Seretide Diskus (salmeterol/fluticasone; 50/100, 50/250 or 50/500 mcg) plus Ventoline (salbutamole) as needed in steroid-treated adult and adolescent asthmatic subjects. A randomised, open, parallel-group, phase IIIB, multicentre, 12-month study.

Medical condition

asthma

Phase

Phase 3

Healthy volunteers

-

Study drug

-

Sex

-

Actual Enrollment

-

Study type

Interventional

Age

-

Date

Study Start Date: 01 Oct 2002
Primary Completion Date: -
Study Completion Date: -

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Nov 2013 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria